Surgery Partners ends Bain Capital buyout talks; reaffirms 2025 guidance

Surgery Partners, Inc.

Special Committee determined that remaining independent provides greater long-term value than Bain Capital's acquisition proposal.
Company reaffirms 2025 revenue guidance of $3.30B-$3.45B and Adjusted EBITDA of $555M-$565M.
Surgery Partners plans to host an Investor Day in H2 2025 to detail growth strategy.
Bain Capital remains a long-term investor and collaborator despite no deal.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.